menu
    • menu

    Company profile for Oncodesign Services

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded over 20 years ago by Dr Philippe Genne, the Company’s CEO and Chairman, Oncodesign is a biopharma company dedicated to the precision medicine. With its unique experience acquired by working with more than 600 clients, including the world’s largest pharmaceutical companies, along with its comprehensive technological platform combining state-of-the-art medicinal chemistry, pharmacology, regulated bioanalysis and medi...
    Founded over 20 years ago by Dr Philippe Genne, the Company’s CEO and Chairman, Oncodesign is a biopharma company dedicated to the precision medicine. With its unique experience acquired by working with more than 600 clients, including the world’s largest pharmaceutical companies, along with its comprehensive technological platform combining state-of-the-art medicinal chemistry, pharmacology, regulated bioanalysis and medical imaging, Oncodesign is able to predict and identify, at a very early stage, each molecule's therapeutic usefulness and potential to become an effective drug.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oncodesign ServicesFrance Flag
    Country
    Country
    France
    Address
    Address
    20 rue Jean Mazen - FR - 21000 Dijon
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncodesign-services.com/
    Linkedin
    Linkedin
    https://fr.linkedin.com/company/oncodesign
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Debiopharm and Oncodesign Services Collaborate on Radiopharmaceut
    Debiopharm and Oncodesign Services Collaborate on Radiopharmaceut

    24 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250424538240/en/Debiopharm-and-Oncodesign-Services-Launch-Strategic-Collaboration-to-Propel-Radiopharmaceuticals-in-Preclinical-Research

    BUSINESSWIRE
    24 Apr 2025
    Share Share
    SEngine, Oncodesign Collaborate for Personalized Cancer Treatment
    SEngine, Oncodesign Collaborate for Personalized Cancer Treatment

    08 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/08/2381219/0/en/SEngine-Precision-Medicine-and-Oncodesign-Announce-Collaboration-Agreement-for-the-Discovery-of-New-Personalized-Cancer-Treatment-for-Aggressive-and-Untreatable-Tumors.html

    GLOBENEWSWIRE
    08 Feb 2022
    Share Share
    Oncodesign and TiumBio Sign Collaborate for R&D of Fibrosis Drug Candidates
    Oncodesign and TiumBio Sign Collaborate for R&D of Fibrosis Drug Candidates

    21 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211020005985/en

    BUSINESSWIRE
    21 Oct 2021
    Share Share
    Oncodesign Reports Its First-half Revenue & Strong Increase in Its Cash PositioN
    Oncodesign Reports Its First-half Revenue & Strong Increase in Its Cash PositioN

    23 Jul 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200723005626/en/Oncodesign-Reports-First-half-Revenue-Strong-Increase-Cash

    BUSINESSWIRE
    23 Jul 2020
    Share Share
    Oncodesign and HitGen Enter Strategic Partnership
    Oncodesign and HitGen Enter Strategic Partnership

    28 May 2020

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2020-05-27/oncodesign-and-hitgen-enter-strategic-partnership/

    CONTRACTPHARMA
    28 May 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search